Logo
About
Blog
OTCIQ
Loading...
   Stock Screener
OTC Markets
Totals
Securities
12,313
Dollar Vol
$2.5B
Share Vol
3.3B
Trades
374,502

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

VPHIF
Valeo Pharma Inc.

Ordinary Shares | Status: Halted
Valeo Pharma Inc. Company Logo

16667 Hymus Blvd.

Kirkland, QC H9H 4R9

Canada

Principal Executive Offices:

16667 Hymus Blvd.

Kirkland, QC H9H 4R9

Canada

Last Verified 08/2024
Business Description
About Valeo Pharma Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology, Neurodegenerative Diseases, Oncology and other specialty products. Headquartered in Kirkland, Quebec, Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.
Financial Reporting
Reporting Status
International Reporting: Toronto Stock Exchange
Audited Financials
Audited
Latest Report
04/30/2024 Interim Financial Report
Fiscal Year End
10/31
Company Officers & Contacts
Steven Saviuk
President

Al Ghaderi Moghaddam
CEO

Pascal Tougas
CFO

Guy Paul Allard
VP, Legal, Corporate Secretary

Frederic Dumais
Director, Comm., IR

Sofia Parvin
Other, Legal Asst.

Board of Directors
Steven Saviuk
Chairman

Charles Bisaillon
Independent Director

Richard Lajoie

Marc Leger
Independent Director, Audit Committee Member

Richard J. Mackay

Robert Lewis Raich
Independent Director

Other Company Insiders
Richard MacKay
100079 Canada Inc.
Steve Saviuk
Manitex Capital Inc.
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Audacie

7055 Boulevard Taschereau

Bureau 500

Brossard, QC J4Z 1A7

Canada

Securities Counsel
McMillan LLP

1000 Sherbrooke 0., #2700

Montreal, QC H3A 3G4

Canada

Profile Data
SIC - Industry Classification
Not Available
Incorporation Information
QC, CA, 2003
Employees
125 as of 07/13/2023
Shell
No
Products and Services

Prescription products in Canada with a focus on Respiratory Diseases, Neurodegenerative Diseases, Oncology and Hospital Specialty Products

Company Facilities

The Company leases office and warehouse space located at 16667, Hymus Blvd., Kirkland, QC, H9H 4R9.

Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.20
Change
-0.1755 (-0.31%)
Bid
56.65
Ask
57.20
Volume
3309
Time
15:55
Contact
Careers
Market Hours
Glossary

© 2025 OTC Markets Group Inc.

Terms of ServiceLinking TermsTrademarksPrivacy StatementCode of ConductRisk WarningSupported BrowsersLimit the Use, Disclosure or Sale of My Personal Information